이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

A Home-Based Study to Enhance Activity in Breast Cancer Survivors

2019년 7월 16일 업데이트: Baystate Medical Center

There is a well-documented association between physical activity & risk for breast cancer development and recurrence. It is known that exercise interventions have been effective at increasing physical activity levels in breast cancer survivors. Knowing that breast cancer survivors are less active than non-cancer patients, a less active lifestyle places them at risk of obesity and poor overall health, which in turn also increases risk of cancer and cancer recurrence. Not all the reasons for the risk reduction are clear, however it is known that hormones and other inflammatory markers play a role.

This study has three goals:

  1. To investigate the feasibility of a home intervention designed to reduce sedentary behavior.
  2. Describe the effects of the intervention on levels of sedentary behavior, physical activity, and symptoms.
  3. Assess cost of the intervention.

연구 개요

상태

완전한

정황

상세 설명

There is a well-documented association between physical activity and risk for breast cancer development and recurrence. Exercise training interventions have been effective at increasing physical activity levels in breast cancer survivors, however they require 1) a large degree of patient initiative to achieve positive health outcomes associated with sustained behavioral change and 2) facilities and oversight that may be prohibitive in a clinical setting. Although most activity-based research to date has focused on increasing levels of moderate to vigorous physical activity (MVPA) for breast cancer survivors, large epidemiological studies suggest that breast cancer survivors are also more sedentary when compared to non-cancer controls. A recent meta-analysis of controlled intervention trials designed to promote physical activity among sedentary cancer survivors found that none of the trials within the scope of the review succeeded in achieving 75% or better adherence to prescribed exercise guidelines, leading the authors to question whether shifting the target of intervention from MVPA to reductions in sedentary time might be a more realistic goal. Recent research suggests that interventions designed to reduce sedentary time in breast cancer survivors have the potential to yield clinically meaningful health benefits, especially for individuals at higher risk for sedentary behaviors, however the optimal method of intervention is not clear.

Aim 1: Feasibility of the intervention Assess the feasibility of an intervention designed to reduce sedentary behavior in breast cancer survivors. The behavioral intervention will involve the review of a 7-day baseline snapshot of sedentary behavior and physical activity patterns, combined with tailored activity prompts described over the following 6 weeks.

Aim 2: Effects of the intervention Aim 2a: Describe a preliminary range of effect sizes of the intervention on levels of sedentary behavior, physical activity and symptoms of cancer survivorship (e.g. cancer related fatigue).

Aim 2b: Evaluate the relationship between change in sedentary behavior and change in cancer-relevant outcomes, such as fatigue and biomarkers of cancer recurrence (e.g. IGF-1, Leptin), following the reduced sedentary time intervention.

Aim 3: Assessment of intervention components Aim 3a: Quantitatively assess overall cost of the intervention and its individual components, dose delivered and dose received by intervention participants Aim 3b: Quantitatively describe intervention participants' perspectives on the impact of the individual intervention components, including which components appeared most useful for reducing sedentary time.

연구 유형

중재적

등록 (실제)

13

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Massachusetts
      • Springfield, Massachusetts, 미국, 01109
        • Baystate Medical Center

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

20년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

여성

설명

Inclusion Criteria:

  • Stage I-III breast cancer survivors 20-80 who have completed primary treatment (surgery, radiation and/or chemotherapy) greater than 6 months but less than 5 years ago. Patients may be on adjuvant hormonal therapy
  • BMI > 25 (overweight or class I/II obese)
  • Not meeting current guidelines for regular exercise as defined by less than 150 minutes a week of moderate to vigorous physical activity
  • No gain or loss of >10% body weight over the prior 6 months.

Exclusion Criteria:

  • Known diabetes
  • Known coronary artery disease
  • Pregnancy
  • Any injury that would limit mobility or require use of assisted mobility devices
  • Weight gain or loss of >10% body weight over the prior 6 months
  • Greater than 150 minutes a week of moderate to vigorous physical activity
  • Inability to provide informed consent
  • Non-english speaking

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
다른: Reduced Sedentary Time Intervention
Reduced Sedentary Time Intervention (RSTI)
Following 7 days of baseline activity monitoring a study investigator will download the information from the monitor, evaluate the periods of sedentary behavior and create a tailored RSTI for each participant. For example, the investigator may notice a long stretch of sitting in the evening following a meal and identify several exercises that can be done indoors during that time, or if the participant is amiable to walking breaks and a period after work is identified the investigator might suggest the appropriate walking activity at that time. This program has been successful in sedentary overweight office workers and investigators will use similar techniques.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Sedentary Time
기간: 8 weeks
Change in minutes/day of sedentary time as recorded by ActivPal in all 25 participants pre and post intervention.
8 weeks

2차 결과 측정

결과 측정
측정값 설명
기간
Activity Level
기간: 8 weeks
Change in Activity level as recorded by Actigraph monitor in all 25 participants
8 weeks
Glucose
기간: 8 weeks
Change in fasting glucose ( mmol/L)in all 25 participants
8 weeks
Insulin
기간: 8 weeks
Change in insulin (pmol/L) in all 25 participants
8 weeks
Total cholesterol
기간: 8 weeks
Change in total cholesterol (mmol) in all 25 participants
8 weeks
High density lipoprotien cholesterol
기간: 8 weeks
Change in high density lipoprotein cholesterol (mmol) in all 25 participants
8 weeks
Triglyceride
기간: 8 weeks
Change in triglycerides (mmol) in all 25 participants
8 weeks
Body Mass Index
기간: 8 weeks
Change in Body Mass Index (kg/m2) in all 25 participants
8 weeks
Waist Circumference
기간: 8 weeks
Change in waist circumference in cm in all 25 participants
8 weeks
Systolic Blood pressure
기간: 8 weeks
Change in systolic blood pressure measured in mmHg in all 25 participants
8 weeks
Diastolic Blood pressure
기간: 8 weeks
Change in diastolic blood pressure measured in mmHg in all 25 participants
8 weeks
Cancer-related fatigue measured by change in PROMIS short form 8a in all 25 participants
기간: 8 weeks
8 weeks
Cancer-related fatigue as measured by change in Visual Analog scale in all 25 participants
기간: 8 weeks
8 weeks
Sedentary behavior self -efficacy
기간: 8 weeks
Change in Sedentary Behavior Self-Efficacy Scale (modified from BARSE) in all 25 participants
8 weeks
Change in EORTC-QLQ-C30 scores in all 25 participants
기간: 8 weeks
8 weeks
Assessment of Intervention
기간: 8 weeks
Change in Assessment of Intervention questions on a scale of 1-5 in all 25 participants
8 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Grace Makari-Judson, MD, Baystate Medical Center

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2016년 10월 1일

기본 완료 (실제)

2018년 10월 1일

연구 완료 (실제)

2018년 10월 1일

연구 등록 날짜

최초 제출

2016년 11월 2일

QC 기준을 충족하는 최초 제출

2016년 11월 17일

처음 게시됨 (추정)

2016년 11월 21일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2019년 7월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2019년 7월 16일

마지막으로 확인됨

2019년 7월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 776553-5

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다